5'-Deoxy-2',3'-di-O-acetyl-5-fluorocytidine
5'-Deoxy-2',3'-di-O-acetyl-5-fluorocytidine (2',3'-Di-O-acetyl-5'-deoxy-5-fluorocytidine) is an antiviral compound that inhibits HBV reverse transcriptase activity. 5'-Deoxy-2',3'-di-O-acetyl-5-fluorocytidine shows potential to control HBV replication in vitro. 5'-Deoxy-2',3'-di-O-acetyl-5-fluorocytidine, as a nucleoside analog, may provide a new option for the suppression of chronic hepatitis B[1].
Product Specifications
CAS Number
161599-46-8
Product Name Alternative
2',3'-Di-O-acetyl-5'-deoxy-5-fluorocytidine
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Endogenous Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/5-deoxy-2-3-di-o-acetyl-5-fluorocytidine.html
Purity
99.77
Smiles
C[C@@H]1[C@@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](N2C=C(F)C(N)=NC2=O)O1
Molecular Formula
C13H16FN3O6
Molecular Weight
329.28
Precautions
H302, H315, H319, H335
References & Citations
[1]Discovering novel direct acting antiviral agents for HBV using in silico screening
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD50 / ICAM3 (CG106), CF647 conjugate, 0.1mg/mL
CD10 (CB-CALLA), CF640R conjugate, 0.1mg/mL
Cytokeratin 14 (LL002), CF740 conjugate, 0.1mg/mL
